bisbenzimidazole has been researched along with B16 Melanoma in 2 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nasr Bouzaiene, N | 1 |
| Chaabane, F | 1 |
| Sassi, A | 1 |
| Chekir-Ghedira, L | 1 |
| Ghedira, K | 1 |
| You, Q | 1 |
| Li, M | 1 |
| Jiao, G | 1 |
2 other studies available for bisbenzimidazole and B16 Melanoma
| Article | Year |
|---|---|
Effect of apigenin-7-glucoside, genkwanin and naringenin on tyrosinase activity and melanin synthesis in B16F10 melanoma cells.
Topics: Animals; Anticarcinogenic Agents; Apigenin; Apoptosis; Bisbenzimidazole; Cell Proliferation; Cell Su | 2016 |
Magnolol induces apoptosis via activation of both mitochondrial and death receptor pathways in A375-S2 cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Biphenyl Compounds; Bisben | 2009 |